These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20173632)

  • 1. Anesthesia for patients with a history of malignant hyperthermia.
    Wappler F
    Curr Opin Anaesthesiol; 2010 Jun; 23(3):417-22. PubMed ID: 20173632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambulatory surgery and malignant hyperthermia.
    Brandom BW
    Curr Opin Anaesthesiol; 2009 Dec; 22(6):744-7. PubMed ID: 19812484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. McArdle's disease and anaesthesia: case reports. Review of potential problems and association with malignant hyperthermia.
    Bollig G; Mohr S; Raeder J
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1077-83. PubMed ID: 16095447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group.
    Rüffert H; Bastian B; Bendixen D; Girard T; Heiderich S; Hellblom A; Hopkins PM; Johannsen S; Snoeck MM; Urwyler A; Glahn KPE;
    Br J Anaesth; 2021 Jan; 126(1):120-130. PubMed ID: 33131754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice.
    Kim TW; Nemergut ME
    Anesthesiology; 2011 Jan; 114(1):205-12. PubMed ID: 21169802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant hyperthermia].
    Glahn KP
    Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anesthesia in malignant hyperthermia susceptible patients.
    Mauritz W; Hackl W; Winkler M; Sporn P; Steinbereithner K
    Acta Anaesthesiol Belg; 1990; 41(2):87-94. PubMed ID: 1973553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anesthesiologic management of susceptible children at risk for malignant hyperthermia].
    Ferrari F; D'Alessandro S; Pietrandrea G; Villani A
    Minerva Anestesiol; 1997 Oct; 63(10):311-4. PubMed ID: 9567608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperthermia and the otolaryngologist.
    Chang CY; Scher RL
    Ear Nose Throat J; 2003 Jun; 82(6):433-6. PubMed ID: 12861868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant hyperthermia--a hereditary and potentially life-threatening condition].
    Haugen T; Toft M; Müller CR; Aasly J
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2792-4. PubMed ID: 16244682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of patients tested for malignant hyperthermia susceptibility.
    Scala D; Di Martino A; Cozzolino S; Mancini A; Bracco A; Andria B; Tammaro A; Savoia G
    Eur J Anaesthesiol; 2006 Sep; 23(9):801-5. PubMed ID: 16780615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant hyperthermia--diagnostics, treatment and anaesthetic management].
    Schuster F; Müller-Reible CR
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Nov; 44(11-12):758-63; quiz 764. PubMed ID: 19918708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia in the otology patient: the UCLA experience.
    Wackym PA; Blackwell KE
    Am J Otol; 1994 May; 15(3):371-5. PubMed ID: 8579142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of malignant hyperthermia susceptibility. 2. Anesthesia for muscle biopsy. Differential diagnosis in negative test results].
    Breucking E; Mortier W
    Anaesthesist; 1993 Oct; 42(10):684-90. PubMed ID: 8250202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of a patient with malignant hyperthermia susceptibility during anesthesia and daily living].
    Jacquot C; Stieglitz P
    Ann Fr Anesth Reanim; 1989; 8(5):417-26. PubMed ID: 2697156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia].
    Navas E; Sánchez-Peña J; Gutiérrez-Crespo A
    Rev Esp Anestesiol Reanim; 1992; 39(5):309-11. PubMed ID: 1410753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of subarachnoid bupivacaine analgesia in malignant hyperthermia-susceptible subjects. A clinical case report].
    Abballe C; Primieri P; De Cosmo G
    Minerva Anestesiol; 1993 Jun; 59(6):335-8. PubMed ID: 8414095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hyperthermia susceptibility: anaesthetic implications and risk stratification.
    Ben Abraham R; Cahana A; Krivosic-Horber RM; Perel A
    QJM; 1997 Jan; 90(1):13-8. PubMed ID: 9093584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: when are they really clean?
    Wappler F
    Anesthesiology; 2011 Aug; 115(2):434-5; author reply 436-7. PubMed ID: 21791992
    [No Abstract]   [Full Text] [Related]  

  • 20. Dantrolene sodium in the management of patients at risk from malignant hyperthermia.
    Bronstein SL; Ryan DE; Solomons CC; Mahowald MC
    J Oral Surg; 1979 Oct; 37(10):719-24. PubMed ID: 289734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.